Bernstein trims AstraZeneca target price
Bernstein cut its target price on AstraZeneca to 198 pounds from 200 pounds while reiterating a constructive long-term view on the drugmaker's pipeline. AstraZeneca shares rose 1% to 120.80 pounds.
Bernstein cut its target price on AstraZeneca to 198 pounds from 200 pounds while reiterating a constructive long-term view on the drugmaker's pipeline. AstraZeneca shares rose 1% to 120.80 pounds.